{
Joe Wolk

People

}

J&J reports strong sales growth for Tremfya and Carvykti amid patent challenges

Johnson & Johnson reported strong sales growth for its cancer therapy Carvykti and immune disease drug Tremfya in Q3, as new approvals expanded their market reach. This growth comes as the company braces for biosimilar competition to its second-best-selling drug, Stelara, expected in January 2025, which saw a 7% sales decline due to insurer rebates. J&J remains optimistic, raising its operational sales guidance for the year, with plans to expand Tremfya into Crohn’s disease and Carvykti's recent FDA approval for earlier treatment in multiple myeloma.
BioPharma Dive
United States Dollar Johnson & Johnson AbbVie Inc. Amgen Inc. USA Joe Wolk Jennifer Taubert Show more
Healthcare, Market Report
14:04 15.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Cryptocurrency & Blockchain Regulations Banking & Investment Regulations Market Sentiment Analysis Decentralized Finance (DeFi) Innovations Anti-Money Laundering (AML) Regulations Inflation Rates & CPI Data Banking Regulations Blockchain Technology Adoption Corporate Responsibility & ESG SEC & Financial Compliance Cryptocurrency Regulations Market Analysis and Predictions Mergers & Acquisitions Tokenomics and Crypto Economics Employment Reports Cryptocurrency Developments
Countries:
USA CHE GBR DEU CHN JPN IND CAN HKG FRA SGP ARE KOR RUS AUS THA TWN BRA KEN LUX
Companies:
Coinbase Global, Inc. Solana USD Apple Inc. Kraken Energy Corp. Credit Suisse High Yield Bond Fund, Inc. Ripple USD USD Ripples USD Bitwise Bitcoin ETF Ethereum USD Tesla, Inc. Chainlink USD VanEck Vietnam ETF BlackRock, Inc. Fidelity Contrafund UBS Group AG NVIDIA Corporation Nasdaq 100 Mar 25 MicroStrategy Inc Grayscale Litecoin Trust Novartis AG
Currencies:
United States Dollar Euro Swiss Franc British Pound Sterling Japanese Yen Chinese Yuan Indian Rupee Australian Dollar Hong Kong Dollar Canadian Dollar South Korean Won Russian Ruble Singapore Dollar Czech Koruna Brazilian Real Romanian Leu Swedish Krona New Taiwan Dollar Iranian Rial Bhutanese Ngultrum
People:
Donald Trump Elon Musk Gary Gensler Paul Atkins Jimmy Carter Ali Martinez Joe Biden Monica Long Brad Garlinghouse Cynthia Lummis David O. Sacks Matt Hougan Jay Clayton Christopher Wallerstedt Rostin Behnam Vivek Ramaswamy Stephen Innes Patrick McHenry Dusty Deevers Shayne Coplan

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.